ARCHIVES

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 19 No. 04 | January 22, 1993

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

Senate Emphasizes Balance In NCI’s Research Programs

September 24, 1993

Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director

September 24, 1976

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

In Brief: Kessler Urges Cardiologists To Fight Teen Smoking; ODAC To Meet Dec. 14

December 1, 1995